The RB tumor suppressor pathway is frequently altered through deletion of CDKN2A (p16; ∼35%) or amplification of CCND1 (cyclin D1; ∼94%) in HNSCC [2, 4, 7, 8]. This evidence concerns the gene CDKN2A and neoplasm.